Audience Quality to Ensure Meaningful TPD Connections
As the 9th TPD & Induced Proximity Summit approaches, senior leaders from across the globe are preparing to head to Boston for 4 days of unparalleled content dedicated to equipping them with the data, insights and connections to advance their own induced proximity pipeline and transform therapeutic strategies across oncology, immunology and neurodegeneration.
Every week we're seeing teams secure their tickets to make the most of our Pre-Conference and Post-Conference Days, plus 3 tracks of content built to provide valuable connections and content for each member of your team - through discovery to clinical development.
To see an exclusive preview of companies in the room, you can download a copy of the event guide - for just 1 week only, get an even more in-depth look at who you could hear from and connect with.
Sample of Who's Already Confirmed:
Recently Confirmed to Attend
- Astellas Pharma
- Nurix Therapeutics
- Novartis
- Amgen
- AstraZeneca
- Parabilis Medicines
- Cytokinetics
- Plexium
- Johnson & Johnson
- Eli Lilly
- General Proximity
- Genosco
- Merck & Co
Teams Attending
- Astellas X12
- Cytokinetics X5
- Daiichi Sankyo X3
- Eli Lilly X3
- Kymera Therapeutics X5
- Parabilis Medicines X4
- Pfizer X4
- Promega X3
- Sibylla Biotech X4
- Quarry Thera X3
- Merck X4
- TRIANA Biomedicines X2
- XtalPi X3
Senior Decision-Makers Joining Daily
- Chief Executive Officer
- Vice President, R&D Engineering
- Vice President, Oncology Research
- Vice President, Chemistry
- Senior Director, Lead Discovery
- Senior Director, TPD Engineering
- Director, Modality Technologies
- Director of Biology
Join the Companies at the Forefront of TPD